Gilead Sciences is a leading biotech company headquartered in Foster City, California, United States. The company was founded in 1987 and has since then been dedicated to discovering, developing, and delivering innovative medicines for life-threatening diseases. Gilead Sciences is a global leader in the research and development of antiviral, oncology, and respiratory therapeutics.

The company has a strong commitment to sustainability and decarbonisation, and has set ambitious goals to reduce its carbon footprint and transition to renewable energy sources. Gilead Sciences recognizes that climate change is one of the biggest challenges facing the world today, and is committed to doing its part to mitigate its impact.

To achieve its sustainability goals, Gilead Sciences has implemented a number of initiatives to reduce its carbon emissions and increase its use of renewable energy. One of these initiatives is the implementation of corporate energy efficiency measures. The company has invested in energy-efficient lighting, heating, and cooling systems, as well as in the use of renewable energy sources such as solar panels and wind turbines.

In addition to energy efficiency measures, Gilead Sciences has also implemented a corporate power purchase agreement (PPA) to increase its use of renewable energy. The company entered into a long-term agreement to purchase renewable energy from a wind farm in Texas, which will provide enough electricity to power its operations in the United States. This PPA will help Gilead Sciences to reduce its carbon footprint and increase its use of renewable energy.

Gilead Sciences has also set a goal to achieve 100% renewable energy for its global operations by 2025. To achieve this goal, the company is exploring a range of renewable energy options, including solar, wind, and geothermal energy. Gilead Sciences is committed to working with its suppliers and partners to transition to renewable energy sources and reduce its carbon footprint.

In addition to its sustainability initiatives, Gilead Sciences is also committed to making a positive impact on the communities it serves. The company has a strong corporate social responsibility program that focuses on improving access to healthcare and education, supporting local communities, and promoting diversity and inclusion.

Gilead Sciences is a leader in the biotech sector, with a strong commitment to sustainability and decarbonisation. The company's initiatives to reduce its carbon footprint and increase its use of renewable energy are a testament to its commitment to sustainability and its responsibility to the environment. Gilead Sciences is setting an example for other companies in the biotech sector and beyond, demonstrating that it is possible to achieve business success while also making a positive impact on the environment and the communities we serve.